Vivanza Biosciences Corporate Filings & Announcements

Latest corporate announcements and filings from Vivanza Biosciences on BSE

Search Inside the pdf :

Vivanza Biosciences Ltd.

04 Dec 2025

2.19

2.82%

Corp. Note

Vivanza Biosciences Ltd - 530057 - Reg. 34 (1) Annual Report.

BSE India

This is to inform that, pursuant to Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation of our intimation dated 04th September, 2025 regarding Submission of Annual Report for the Financial Year 2024-25, the Company hereby submits the revised Annual Report for the F.Y. 2024- 25. We further wish to state that the previous Annual Report contained improper formatting and changes, which are being revised in this revised Annual Report.

pdf

Vivanza Biosciences Ltd.

15 Nov 2025

2.19

2.82%

Company Update

Vivanza Biosciences Ltd - 530057 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby enclose the copies of the postal ballot notice for seeking approval of members of the company, the amendementof the Object Clause of the Memorandum of Association (MOA) of the Company as published in the following newspaper: 1. Indian Express, in English 2. Financial Express, in Gujrati

pdf

Vivanza Biosciences Ltd.

14 Nov 2025

2.19

2.82%

AGM

Vivanza Biosciences Ltd - 530057 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby submit the postal ballot notice for seeking Members'' approval for the alteration of the Object Clause of the MOA. The notice has been sent to Members whose names appear in the Register of Members/Beneficial Owners and whose email IDs are registered with the Company/ Depositories as on the cut-off Date 07/11/2025. Members holding Shares in Physical mode who have not registered their email IDs are requested to update the same as per the instructions in the Notice. The Company has Appointed M/s Purva Sharegistry (India) Private Limited for remote e-voting. The e-voting period will be from 9:00 a.m on November 17th, 2025, to 5:00 p.m on December, 16th, 2025after which the E-voting modulke will be diabled

pdf

Vivanza Biosciences Ltd.

14 Nov 2025

2.19

2.82%

Result

Vivanza Biosciences Ltd - 530057 - Results - Financial Results For 30Th September, 2025

BSE India

Pursuant to regulations 30 & 33 of SEBI (LODR), we inform that the Board at its meeting held on November 11, 2025, approved: 1. Un-audited & Standalone Financial results for the quarter ended 3.09.2025, along with a limited review report. 2. Appointment of CS Chaitra Arora (M. No.: A78376) as Company Secretary and Compliance Officer 3. Noted resignation of CS Siddhi Shah (A44885) w.e.f 26.09.2025 4. Alteration of the main object clause of the MOA , subject to approvals, related disclosure enclosed. 5. Approval of revised Object clause to include activities relating to plastic polymer films, packaging material, etc., subject to postal ballot approval. 6. Approval of Postal Ballot Calendar, Postal Ballot Notice Cut-off date 07-11-2025, and appointment of Scrutinizer Mr. Chintan K. Patel (M. No.: A31987)

pdf

	Sep 2025	Jun 2025	Sep 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	55.37	8.96	3.00	518.0%	1745.7%
Operating Profit Qtr	0.61	0.15	0.11	306.7%	454.5%
Net Profit Qtr	0.56	0.09	0.02	522.2%	2700.0%
Earning Per Share Adjusted latest Qtr	0.14	0.02	0.00	600.0%	-

* Consolidated data

Detailed Results

Vivanza Biosciences Ltd.

13 Nov 2025

2.19

2.82%

Company Update

Vivanza Biosciences Ltd - 530057 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI (LODR) 2015, please find enclosed copies of the newspaper advertisement published in India Express (English) and Financial Express (Gujarati) for the Extract of Unaudited Standalone and Consolidated Financial Results for the Quarter ended September 30, 2025

pdf

Vivanza Biosciences Ltd.

11 Nov 2025

2.19

2.82%

Company Update

Vivanza Biosciences Ltd - 530057 - Non-Applicability Of Disclosure Under Regulation 23(9) Of SEBI (LODR) Regulations, …

BSE India

Announcement regarding Non-Applicability of Related Party Transaction under Regulation 23(9) of SEBI LODR

pdf

Vivanza Biosciences Ltd.

11 Nov 2025

2.19

2.82%

Company Update

Vivanza Biosciences Ltd - 530057 - Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 …

BSE India

Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015, attaching herewith Non-Applicability of Statement of deviation or variation

pdf

Vivanza Biosciences Ltd.

11 Nov 2025

2.19

2.82%

Company Update

Vivanza Biosciences Ltd - 530057 - Postal Ballot For Alteration Of The Main Object Clause Of …

BSE India

The board has approved conducting a Postal Ballot to seek members'' consent for altering the main Object clause of Memorandum of Association. Members whose name appears in the Register of members/Beneficial Owners as on Friday, November 7th 2025. Shall be eligeble to vote. The notice will be dispatched electronically by November 14th 2025. Mr. Chintan K. Patel Company Secretary (M. No. A31987, COP 11959), has been appointed as the scruitneser for the process.

pdf

Vivanza Biosciences Ltd.

11 Nov 2025

2.19

2.82%

Result

Vivanza Biosciences Ltd - 530057 - Financial Results For The Quarter Ended 30Th September, 2025

BSE India

Pursuant to Regulation 30 and 33 of the SEBI (LODR) Regulations, 2015 we wish to inform that the board of directors at its meeting held tuesday 11th November, 2025 has inter alia considered and approved (1) unaudited standalone and consolidated financial results for the quarter ended 30th September, 2025 alongwith the limited review report (2) Appointment of CS Chaitra Arora (M.No. A78376) as Company Secretary & compliance officer and noted the resignation of CS siddhi shah (M. No. A44885) (3) Alteration of main object clause of the Memorandum of association to include manufacturing and trading of plastic and packaging materials subject to shareholders'' approval via postal ballot (4) Approval of postal ballot notice, calendar of events, cut- off date of 7th November, 2025 and appointment of Mr. Chintan K. Patel as a Scrutinizer.

pdf

	Sep 2025	Jun 2025	Sep 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	55.37	8.96	3.00	518.0%	1745.7%
Operating Profit Qtr	0.61	0.15	0.11	306.7%	454.5%
Net Profit Qtr	0.56	0.09	0.02	522.2%	2700.0%
Earning Per Share Adjusted latest Qtr	0.14	0.02	0.00	600.0%	-

* Consolidated data

Detailed Results

Vivanza Biosciences Ltd.

11 Nov 2025

2.19

2.82%

Board Meeting

Vivanza Biosciences Ltd - 530057 - Board Meeting Outcome for The Board Meeting Held On 11Th …

BSE India

Pursuant to Regulations 30 and 33 of the SEBI (LODR) Regulations, 2015, we wish to inform that the Board of Directors, at its meeting held on Tuesday, 11th November, 2025, has inter alia considered and approved: (1) Un-Audited Standalone and Consolidated Financial Results for the quarter ended 30th September, 2025, along with the Limited Review Report; (2) Appointment of CS Chaitra Arora (M. No. A78376) as Company Secretary & Compliance Officer and noted the resignation of CS Siddhi Shah (M. No. A44885); (3) Alteration of the Main Object Clause of the Memorandum of Association to include manufacturing and trading of plastic and packaging materials, subject to shareholders' approval via Postal Ballot; (4) Approval of Postal Ballot Notice, Calendar of Events, cut-off date of 7th November, 2025, and appointment of Mr. Chintan K. Patel, PCS, as Scrutinizer.

pdf

Is Vivanza Biosciences Ltd. worth buying?

27 Votes:

Buy 62.96%

Sell 14.81%

Hold 22.22%